As a patient at MSK, your child or young adult may be able to take part in a clinical trial, also known as a clinical research study. In a clinical trial, doctors evaluate a new therapy or a therapy combination to find out whether it is more effective than current Ewing sarcoma treatments. Nearly every cancer treatment used today exists because of a clinical trial. For every trial, the goal is the same: to provide long-term, disease-free survival.
Our patients have access to many of the latest clinical trials, some of which are only available at MSK. We also participate in many nationwide clinical trials as a founding member of the Children’s Oncology Group, as the coordinating center and co-founder of the Pediatric Oncology Experimental Therapeutics Investigators’ Consortium, and through other trial networks across the United States.
The decision to have your child take part in a clinical trial is entirely up to you and your family. Regardless of whether your child receives standard treatment or therapy through a clinical trial, he or she will benefit from MSK’s ongoing commitment to excellence in patient care.
One of our clinical trials for newly diagnosed Ewing sarcoma patients builds on our success from a previous trial. In the past, we have shown that patients with Ewing sarcoma whose disease returned after conventional therapy responded well to the combination of two drugs, irinotecan and temozolomide. We have added these medicines to the others that have been traditionally used to treat newly diagnosed Ewing sarcoma.
Learn more about MSK’s current clinical trials for Ewing sarcoma.